GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$9.42B
This Quarter Return
+5.45%
1 Year Return
+54.36%
3 Year Return
+272.74%
5 Year Return
+377.85%
10 Year Return
+3,143.71%
AUM
$7.98B
AUM Growth
+$7.98B
(-0.27%)
Cap. Flow
+$382M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
73
Reduced
147
Closed
36
Top Buys
| 1 |
NVIDIA
NVDA
|
$387M |
| 2 |
Boston Scientific
BSX
|
$86.9M |
| 3 |
Embraer
ERJ
|
$53.6M |
| 4 |
BBB Foods
TBBB
|
$40.6M |
| 5 |
Natera
NTRA
|
$38.3M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$171M |
| 2 |
Intel
INTC
|
$51.3M |
| 3 |
Denali Therapeutics
DNLI
|
$24.1M |
| 4 |
Netflix
NFLX
|
$21.9M |
| 5 |
Palo Alto Networks
PANW
|
$18.6M |
Sector Composition
| 1 | Technology | 31.67% |
| 2 | Consumer Discretionary | 19.21% |
| 3 | Healthcare | 16.8% |
| 4 | Communication Services | 13.51% |
| 5 | Industrials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
MarketAxess Holdings
MKTX
$6.87B
| $1.12M | 0.01% | 5,588 +1 | +0% | +$201 |
|
|
AZUL
202
DELISTED
Azul
AZUL
| $1.09M | 0.01% | 272,560 -239,802 | -47% | -$959K |
|
203
TG Therapeutics
TGTX
$4.65B
| $1.08M | 0.01% | +60,673 | New | +$1.08M |
|
|
SILK
204
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.06M | 0.01% | 39,372 +4,440 | +13% | +$120K |
|
|
SKE
205
Skeena Resources
SKE
$1.93B
| $1.03M | 0.01% | 192,511 -193,972 | -50% | -$1.04M |
|
206
Exact Sciences
EXAS
$8.98B
| $998K | 0.01% | 23,631 -420 | -2% | -$17.7K |
|
207
Vertex Pharmaceuticals
VRTX
$100B
| $969K | 0.01% | 2,067 +273 | +15% | +$128K |
|
208
Howmet Aerospace
HWM
$70.2B
| $882K | 0.01% | 11,359 -36 | -0.3% | -$2.8K |
|
209
Clean Harbors
CLH
$13B
| $869K | 0.01% | 3,842 +2 | +0.1% | +$452 |
|
210
Applied Materials
AMAT
$128B
| $853K | 0.01% | +3,613 | New | +$853K |
|
211
EchoStar
SATS
$17.8B
| $841K | 0.01% | 47,210 -353 | -0.7% | -$6.29K |
|
212
Snap
SNAP
$12.1B
| $827K | 0.01% | 49,798 -38 | -0.1% | -$631 |
|
213
Ultragenyx Pharmaceutical
RARE
$2.89B
| $819K | 0.01% | 19,927 +2,504 | +14% | +$103K |
|
214
FinWise Bancorp
FINW
$261M
| $776K | 0.01% | 76,011 -125,077 | -62% | -$1.28M |
|
|
AZEK
215
DELISTED
The AZEK Co
AZEK
| $774K | 0.01% | 18,368 +153 | +0.8% | +$6.45K |
|
216
Cytokinetics
CYTK
$4.23B
| $749K | 0.01% | 13,830 -221 | -2% | -$12K |
|
217
Philip Morris
PM
$260B
| $743K | 0.01% | 7,332 -108 | -1% | -$10.9K |
|
|
IAUX
218
i-80 Gold Corp
IAUX
$653M
| $724K | 0.01% | 670,115 -14,518 | -2% | -$15.7K |
|
219
SS&C Technologies
SSNC
$21.7B
| $659K | 0.01% | 10,518 -38,862 | -79% | -$2.44M |
|
220
Transocean
RIG
$2.86B
| $639K | 0.01% | 119,519 -24,396 | -17% | -$131K |
|
221
Dyne Therapeutics
DYN
$1.92B
| $619K | 0.01% | +17,546 | New | +$619K |
|
222
ACM Research
ACMR
$1.81B
| $612K | 0.01% | 26,530 -191 | -0.7% | -$4.4K |
|
223
Eaton
ETN
$136B
| $604K | 0.01% | 1,927 -1 | -0.1% | -$314 |
|
224
Crinetics Pharmaceuticals
CRNX
$2.92B
| $575K | 0.01% | +12,836 | New | +$575K |
|
|
ENFN
225
DELISTED
Enfusion, Inc.
ENFN
| $556K | 0.01% | 65,270 +10,351 | +19% | +$88.2K |
|